SEC Form 4 · accession 0000899243-17-016623
OMEROS CORP · OMER
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter A Demopulos M.D.
Director
Period of report
Jun 16, 2017
Accepted (ET)
Jun 16, 2017 · 8:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001285819
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $23.75 | Jun 16, 2017 | A | 10,000 | A | — | Jun 15, 2027 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1This option will fully vest and become exercisable on the day before the date of the 2018 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date.